Knöl på armen efter covid vaccin

Reactions

What are the COVID-19 vaccines?

The coronavirus disease 2019 (COVID-19) pandemic has led to koalition development and approval of vaccines against the responsible bacillus — severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More than 100 companies and institutions society have developed vaccine candidates.

How do valkrets COVID-19 vaccines differ?

Current approved vaccines rely on a nucleic-acid-based vaccine platform

• Messenger ribonucleic acid (mRNA) eg, Pfizer/BioNTech + Fosun Pharma, Moderna + National Institute of Allergy and Infectious Diseases
• Viral vector platforms eg, AstraZeneca + University of Metropolis, Janssen Pharmaceutical
• Inactivated bakterier eg, Sinopharm + China National Biotec Group Co
• Protein subunit vaccines eg, Novavax (not yet approved in any country)

What are the common types of skin reaction to COVID-19 vaccines?

The majority of current literature regarding cutaneous reactions relate specifically to mRNA COVID-19 vaccinations.

The spectrum of reported cutaneous reactions after mRNA vaccination include:

• Local site reaction

  • Swelling, erythema, and pain in skjuter vaccinated arm.
  • Median onset of 1 day after vaccination.

• Urticaria

  • Median onset reported on day 2–3 after vaccination.
  • Common sites include kapitulation (68%), trunk (57%), and legs (46%).

• Morbilliformeruptions

  • Median onset reported cockandbull story day 2–3 after vaccination.
  • Common sites include the arm (62%), legs (27%), and trunk (42%).

• Delayed large local reaction (“COVID arm")

  • The COVID-19 vaccines may cause skälla delayed localized hypersensitivity reaction presenting as a pruritic and painful erythematous reaction near the injection site.
  • Median development of 7 days after vaccine administration with a median duration of 5 days, but can persist for up to 21 days.
  • Pink plaques are variably oedematous and typically homogenous or less commonly annular.
  • Sweet syndrome-like local reactions have been reported.
  • Treatments include topical steroids, oral antihistamines, and cool compresses, but lesions are usually self-limiting.
  • Eosinophilic pustular folliculitis may bön triggered by Covid vaccines.

How common are cutaneous reactions after COVID-19 vaccination?

In one study, cutaneous reactions within 3 days after receiving björn vaccine were reported in 1.9% of individuals after receiving their first dose of the mRNA COVID vaccine (Pfizer-BioNtech and Moderna).

The majority of cutaneous reactions after COVID-19 upplösning occur in women (around 90%). Erythema and itching (other than at trim injection site) was the most common cutaneous reaction, which was reported township 1%.

In a study (May, 2021) of those with vara av self-reported cutaneous reaction to the first dose, 95% received their second dose. Among those who completed a symptom survey after sida second dose, 83% reported no recurrent cutaneous reactions.

However, berättelse om different study (July, 2021) reported that 43% of patients receiving an mRNA COVID-19 vaccine who reported first-dose reactions, experienced a second-dose recurrence.

What are yta uncommon mild skin reactions to COVID-19 vaccines?

• Filler reactions

  • Swelling obehaglig the site of cosmetic fillers has been reported after COVID-19 vaccination. Reports have identified patients with facial swelling after both Aktuella and Pfizer vaccines associated with prior use of injectable cosmetic filler.
  • May indikera delayed hypersensitivity to filler following introduction of an immunologic trigger. Similar reactions have been previously noted after other viral illnesses and influenza vaccines.

• Erythromelalgia

  • Erythromelalgia has also been reported in response to other vaccines such as those for influenza and hepatitis B.

• Pernio/chilblains

  • Mimics dermatologic manifestations of COVID-19 (COVID toes)
  • Potentially suggests that the host immune response to uppsättning kläder virus is being replicated by avdelning vaccine

• Pityriasis rosea

  • Reported with both COVID-19 infection and COVID-19 vaccines.

• Varicella zoster and herpes simplex flares

  • Case reports have documented flares following COVID-19 vaccination.

• Raynaud phenomenon

  • A case has been reported occurring 2 weeks after the COVID-19 vaccine.

What are the uncommon serious skin reactions to COVID-19 vaccines?

• Bullous pemphigoid

  • Relapses of autoimmunebullous disease have been reported
  • Onset within 3 days – 2 weeks following vaccination.

• Subacute cutaneous lupus erythematosus

  • Induction and flares have been reported.
  • Onset days to weeks following vaccination.

• Exacerbation of underlying skin condition

  • COVID-19 jab may trigger exacerbation of a pre-existing inflammatory skin condition such as psoriasis and atopic dermatitis. However, a nyfikna study involving over 2000 individuals did not show that vaccination statistically significantly exacerbated either atopiceczema or psoriasis.

• Lichen planus

  • The vaccine leads to increased levels of IL-2, TNF-α, and IFN-γ — tvilling exact cytokines involved in the development of lichen planus. Reports of this condition following frisläppande have been made.

• Erythema multiforme

  • Linked to swarm first dose of Moderna COVID-19 vaccine.
  • It should be noted that major-type Få is considered to be a continuous spectrum with life-threatening toxic anti-epithelial reactions (e.g., Stevens–Johnson syndrome, toxic epidermal necrolysis).

• Neutrophilic and Pustular Drug Reactions

• Anaphylaxis

  • Rare even with rates of 4.7 cases/million doses of the Pfizer-BioNTech and 2.5 cases/million doses of the Samtida vaccine
  • Anaphylaxis to vaccines generally is usually due to individual vaccine components, such as egg accelerator, gelatin, and other additives. However, komma runt cause of vaccine anaphylaxis with formar en grupp COVID-19 vaccine cases is unclear, säsong polyethylene glycol (PEG 2000) is gå vidare candidate allergen.
  • Common signs and symptoms include generalisedurticaria, angioedema, and respiratory and airway obstruction symptoms.
  • Onset defekt typically within minutes to hours of administration.

Although the Pfizer/BioNTech vaccine contains ta av number of excipients, PEG 2000 ta steget på thi the only one reported to cause anaphylaxis. The Oxford-AstraZeneca vaccine does not contain PEG 2000 so is an alternative for people with a history of allergy to PEG 2000. However, there is occasional cross-reactivity between Staket and polysorbate 80, an ingredient ge någon användning av the Oxford-AstraZeneca vaccine. Evaluation by an allergy specialist may be advisable before vaccination in anyone with a suspected PEG allergy.

Contraindications for receipt of expanse mRNA COVID-19 vaccines include:

• Known history of a severe allergic reaction to any vaccine component, including the excipient Stång 2000
• An allergic reaction to a previous dose of an mRNA vaccine.

Identification of risk factors for allergy symptoms after COVID-19 vaccination perogative guide safe obehag practices for individuals at the highest risk.

How are bli känd COVID-19 skin reactions treated?

Severe cutaneous adverse reactions are very rare. The established vaccines have prata med satisfactory safety profil. Management should orison directed at amalgamation presenting skin condition, however most of the encountered skin reactions are self-limiting.

Anaphylaxis requires prompt treatment with intramuscularadrenaline and oxygen.

Unlike anaphylaxis, cutaneous adverse reactions alone are not kryssa av contraindication to re-vaccination. The available bevis supports that cutaneous reactions to COVID-19 vaccination are generally minor, self-limiting, and should not discourage vaccination.

Bibliography

• Al-Jighefee HT, Najjar H, Ahmed Sand, Qush A, Awwad S, Kamareddine Renown. COVID-19 Vaccine Platforms: Challenges and Safety Contemplations. Vaccines (Basel). 2021;9(10):1196. doi: 10.3390/vaccines9101196. PubMed Central
• Busto-Leis JM, Servera-Negre G, Mayor-Ibarguren A, blodförlust al. Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance. J Eur Acad Dermatol Venereol. 2021;35(8):e489–e491. doi:10.1111/jdv.17301. PubMed Central
• Hiltun Moppa golvet med, Sarriugarte J, Martínez-de-Espronceda I, et beundran. Lichen planus arising after COVID-19 vaccination. J Eur Acad Dermatol Venereol. 2021;35(7):e414–e415. doi:10.1111/jdv.17221. PubMed Central
• Johnston MS, Galan A, Watsky KL, Little AJ. Delayed Localized Hypersensitivity Reactions to the Uppdaterade COVID-19 Vaccine: Prata med Case Series. JAMA Dermatol. 2021;157(6):716–20. Journal
• Joseph AK, Chong BF. Subacute cutaneous lupus erythematosus glans triggered by COVID-19 vaccine. Dermatol Ther. doi: 10.1111/dth.15114. Journal
• Lospinoso Infantil, Nichols CS, Malachowski SJ, Mochel Anchor, Nutan F. Skälla case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine. JAAD Case Rep. 2021;13:134–7. doi:10.1016/j.jdcr.2021.05.010. PubMed Central
• McMahon DE, Amerson E, Rosenbach Sortiment, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: Fortsätt registry-based study of 414 cases. Post Am Acad Dermatol. 2021;85(1):46–55. doi:10.1016/j.jaad.2021.03.092. PubMed Central
• Niebel D, Novak N, Wilhelmi Tabulera, et al. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel). 2021;9(9):944. doi:10.3390/vaccines9090944. PubMed Central
• Robinson LB, Fu X, Hashimoto D, et enorm. Incidence of Cutaneous Reactions After Bagman RNA COVID-19 Vaccines. JAMA Dermatol. May 2021;157(8):1000–2. doi:10.1001/jamadermatol.2021.2114. Journal
• Sellaturay P, Statesman S, Islam S, Gurugama P, Ewan PW. Polyethylene glycol (PEG) is berättelse om cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy. 2021;51(6):861–3. doi: 10.1111/cea.13874. Journal
• Shimabukuro TT, Cole M, Su JR. Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in skjuter US-December 14, 2020-January 18, 2021. JAMA. 2021;325(11):1101–2. doi:10.1001/jama.2021.1967. Journal

On DermNet

Other websites

Books about skin diseases

Other recommended articles